Dr. Shasank Sekhar Swain
Centurion University of Technology and Management, BRIC-Institute of Life Sciences, IMS & SUM Hospital, Siksha 'O' Anusandhan University, BJB Autonomous College, Utkal University
0000-0001-5089-8304
About
Dr. Shasank Sekhar Swain (MSc, PhD, FICS) is an Indian biomedical scientist specializing in bioinformatics, structural biology, drug design and synthesis, and network biology and pharmacology. His research focuses on hybrid drug development, computer-aided drug design, natural product-based therapeutics, and antibacterial drug discovery. He has been supported by the DHR-Young Scientist award and the ICMR-Post Doctoral Research Fund from the Department of Health Research and the Indian Council of Medical Research, Government of India. He received the prestigious Odisha Young Scientist Award-2020 (Life Science) from the Odisha Bigyan Academy, Department of Science and Technology, Government of Odisha, for his innovative research on hybrid drug development strategies. He was also honored with the Rajdhani Gaurav Samman-2025 by the Hon'ble Governor of Odisha in recognition of his contributions to medical science. Dr. Swain has been listed among Stanford–Elsevier's World's Top 2% Scientists for three consecutive years (2023–2025) in the sub-categories of Medicinal & Biomolecular Chemistry and Pharmacology & Pharmacy. He is further recognized by SciRank Global as among the World's Top 5% Scientists (2025).
Employment
-
Centurion University of Technology and Management Assistant Professor2026 - Present
-
BRIC-Institute of Life Sciences Postdoctoral Research Associate -I2022 - 2025
-
ICMR-Regional Medical Research Centre ICMR Centenary-Post Doctoral Fellow2020 - 2022
-
ICMR-Regional Medical Research Centre DHR-Young Scientist Fellow2018 - 2020
Education
-
IMS & SUM Hospital, Siksha 'O' Anusandhan University PhD (Biotechnology)2014 - 2018
-
BJB Autonomous College, Utkal University MSc2010 - 2012
Projects & Funding
Projects & funding information is unavailable.
Publications (43)
- Exploration of Bioactive Compounds in Benincasa hispida Seeds: Insight Into Their Therapeutic Potential for Alzheimer's Disease Management Using Computer‐Aided Drug Design Platform Save
- Synthesis, spectroscopic analysis, and computational-based investigations on ‘azo-coumarin-Co(II)-galangin’ hybrids exhibit multipotential activities Save
- Quantitative Phytochemical Investigation, Antibacterial Potency, and Drug-ability Assessment of Three Indian Medicinal Plants Leaf Extracts Using Bioinformatics Tools Save
- Piperlongumine and its derivatives against cancer: A recent update and future prospective Save
- Antibacterial Activity, Toxicity and Drug-Likeness Profiles of Woodfordia fruticosa-Derived Metabolites Using Computational-Aided Drug Design Platform Save
- Natural Compounds Isolated from African Mistletoes (Loranthaceae) Exert Anti-Inflammatory and Acetylcholinesterase Inhibitory Potentials: In Vitro and In Silico Studies Save
- In vitro profiling and functional assessments of the anti‐diabetic capacity of phenolic‐rich extracts of Bulbine natalensis and Bulbine frutescens Save
- Novel Caffeic Acid - Zinc Acetate Complex: Studies on Promising Antidiabetic and Antioxidative Synergism Through Complexation Save
- Nano-technology platforms to increase the antibacterial drug suitability of essential oils: A drug prospective assessment Save
- The anticandidal activity of the diterpenediol 8(14),15‐sandaracopimaradiene‐7alpha,18‐diol from Tetradenia riparia against the emerging pathogen Candida auris Save